Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Below Fifty Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price passed below its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $67.32 and traded as low as $65.9101. Novozymes A/S shares last traded at $66.25, with a volume of 352,236 shares traded.

Novozymes A/S Trading Down 3.4%

The business has a 50 day simple moving average of $67.32 and a two-hundred day simple moving average of $62.69. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 0.25. The stock has a market cap of $27.46 billion, a price-to-earnings ratio of 39.20, a price-to-earnings-growth ratio of 3.08 and a beta of 0.86.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.26). Novozymes A/S had a return on equity of 6.56% and a net margin of 15.59%. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.28 billion. As a group, equities analysts anticipate that Novozymes A/S will post 2.45 EPS for the current year.

Institutional Trading of Novozymes A/S

An institutional investor recently raised its position in Novozymes A/S stock. Elefante Mark B increased its stake in Novozymes A/S (OTCMKTS:NVZMY) by 73.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,900 shares of the biotechnology company’s stock after buying an additional 2,500 shares during the period. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 at the end of the most recent reporting period. 0.03% of the stock is currently owned by institutional investors.

About Novozymes A/S

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.